Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology

[1]  Andrei I Holodny,et al.  Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients. , 2018, Cancer research.

[2]  Albert P. Chen,et al.  Sensitivity enhancement for detection of hyperpolarized 13C MRI probes with 1H spin coupling introduced by enzymatic transformation in vivo , 2018, Magnetic resonance in medicine.

[3]  Daniel B Vigneron,et al.  3D hyperpolarized C-13 EPI with calibrationless parallel imaging. , 2018, Journal of magnetic resonance.

[4]  Adam B Kerr,et al.  Technique development of 3D dynamic CS‐EPSI for hyperpolarized 13C pyruvate MR molecular imaging of human prostate cancer , 2018, Magnetic resonance in medicine.

[5]  Ilwoo Park,et al.  Development of methods and feasibility of using hyperpolarized carbon‐13 imaging data for evaluating brain metabolism in patient studies , 2018, Magnetic resonance in medicine.

[6]  C. Thompson,et al.  In Vivo Imaging of Glutamine Metabolism to the Oncometabolite 2-Hydroxyglutarate in IDH1/2 Mutant Tumors. , 2017, Cell metabolism.

[7]  Rahul Aggarwal,et al.  Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer. , 2017, European urology.

[8]  M. Pourfathi,et al.  In vivo pH mapping of injured lungs using hyperpolarized [1‐13C]pyruvate , 2017, Magnetic resonance in medicine.

[9]  Sun Mi Park,et al.  Real-time quantitative analysis of metabolic flux in live cells using a hyperpolarized micromagnetic resonance spectrometer , 2017, Science Advances.

[10]  Julie L. Proctor,et al.  Metabolic imaging of energy metabolism in traumatic brain injury using hyperpolarized [1-13C]pyruvate , 2017, Scientific Reports.

[11]  D. Mankoff,et al.  Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review , 2017, JAMA oncology.

[12]  John Kurhanewicz,et al.  Development of high resolution 3D hyperpolarized carbon-13 MR molecular imaging techniques. , 2017, Magnetic resonance imaging.

[13]  John Kurhanewicz,et al.  Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion. , 2017, Cancer research.

[14]  M. Pourfathi,et al.  The use of hyperpolarized carbon‐13 magnetic resonance for molecular imaging☆ , 2017, Advanced drug delivery reviews.

[15]  D. Spielman,et al.  In vivo assessment of intracellular redox state in rat liver using hyperpolarized [1‐13C]Alanine , 2017, Magnetic resonance in medicine.

[16]  Daniel B Vigneron,et al.  Development of a symmetric echo planar imaging framework for clinical translation of rapid dynamic hyperpolarized 13C imaging , 2017, Magnetic resonance in medicine.

[17]  Matthew D. Robson,et al.  Simultaneous assessment of cardiac metabolism and perfusion using copolarized [1‐13C]pyruvate and 13C‐urea , 2016, Magnetic resonance in medicine.

[18]  K. Brindle,et al.  Assessing Oxidative Stress in Tumors by Measuring the Rate of Hyperpolarized [1-13C]Dehydroascorbic Acid Reduction Using 13C Magnetic Resonance Spectroscopy* , 2016, The Journal of Biological Chemistry.

[19]  Albert P. Chen,et al.  Hyperpolarized 13 C Metabolic MRI of the Human HeartNovelty and Significance : Initial Experience , 2016 .

[20]  K. Brindle,et al.  Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response , 2016, Clinical Cancer Research.

[21]  S. Neubauer,et al.  Assessment of Metformin-Induced Changes in Cardiac and Hepatic Redox State Using Hyperpolarized[1-13C]Pyruvate , 2016, Diabetes.

[22]  C. Najac,et al.  Detection of inflammatory cell function using 13C magnetic resonance spectroscopy of hyperpolarized [6-13C]-arginine , 2016, Scientific Reports.

[23]  R. Braren,et al.  Multiparametric human hepatocellular carcinoma characterization and therapy response evaluation by hyperpolarized 13C MRSI , 2016, NMR in biomedicine.

[24]  E. Mittra,et al.  Response Assessment Criteria and Their Applications in Lymphoma: Part 1 , 2016, The Journal of Nuclear Medicine.

[25]  D. Mankoff,et al.  ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI , 2016, Clinical Cancer Research.

[26]  T. Jang,et al.  Hyperpolarized 13C‐lactate to 13C‐bicarbonate ratio as a biomarker for monitoring the acute response of anti‐vascular endothelial growth factor (anti‐VEGF) treatment , 2016, NMR in biomedicine.

[27]  J. Costello,et al.  Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters , 2016, Oncotarget.

[28]  J. Kurhanewicz,et al.  Non-Invasive Differentiation of Benign Renal Tumors from Clear Cell Renal Cell Carcinomas Using Clinically Translatable Hyperpolarized 13C Pyruvate Magnetic Resonance , 2016, Tomography.

[29]  He N. Xu,et al.  Differentiating inflamed and normal lungs by the apparent reaction rate constants of lactate dehydrogenase probed by hyperpolarized (13)C labeled pyruvate. , 2016, Quantitative imaging in medicine and surgery.

[30]  J. Phillips,et al.  MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival , 2016, Molecular Cancer Therapeutics.

[31]  J. Cairncross,et al.  Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring , 2016, NeuroImage: Clinical.

[32]  Paul Kinahan,et al.  Quantitative Imaging in Cancer Clinical Trials , 2016, Clinical Cancer Research.

[33]  Christine E. Edmonds,et al.  Development of Companion Diagnostics. , 2016, Seminars in nuclear medicine.

[34]  Michael Lustig,et al.  Development and testing of hyperpolarized (13)C MR calibrationless parallel imaging. , 2016, Journal of magnetic resonance.

[35]  Marc S Ramirez,et al.  Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. , 2015, Cancer research.

[36]  Majbrit M E Larsen,et al.  Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer , 2015, The Journal of Nuclear Medicine.

[37]  J. Kurhanewicz,et al.  Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor , 2015, The Prostate.

[38]  K. Keshari,et al.  13C-labeled biochemical probes for the study of cancer metabolism with dynamic nuclear polarization-enhanced magnetic resonance imaging , 2015, Cancer & Metabolism.

[39]  Fenghai Duan,et al.  A Phase II Study of 3′-Deoxy-3′-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688 , 2015, The Journal of Nuclear Medicine.

[40]  D. Tuveson,et al.  MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model , 2015, Gut.

[41]  John Kurhanewicz,et al.  Real‐time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor , 2015, NMR in biomedicine.

[42]  R. Gillies,et al.  Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. , 2015, Cancer research.

[43]  G. Radda,et al.  Robust hyperpolarized 13C metabolic imaging with selective non‐excitation of pyruvate (SNEP) , 2015, NMR in Biomedicine.

[44]  Drew A. Torigian,et al.  Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials , 2015, The Journal of Nuclear Medicine.

[45]  S. Weiss,et al.  IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. , 2015, Cancer research.

[46]  E. Gottlieb,et al.  Research into cancer metabolomics: Towards a clinical metamorphosis. , 2015, Seminars in cell & developmental biology.

[47]  L. Pusztai,et al.  The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming , 2015, Nature Communications.

[48]  A. Haase,et al.  Quantified pH imaging with hyperpolarized 13C‐bicarbonate , 2015, Magnetic resonance in medicine.

[49]  V. Positano,et al.  Real-time cardiac metabolism assessed with hyperpolarized [1-(13) C]acetate in a large-animal model. , 2015, Contrast media & molecular imaging.

[50]  K. Keshari,et al.  Novel Approaches to Imaging Tumor Metabolism , 2015, Cancer journal.

[51]  James B. Mitchell,et al.  13C-MR Spectroscopic Imaging with Hyperpolarized [1-13C]pyruvate Detects Early Response to Radiotherapy in SCC Tumors and HT-29 Tumors , 2015, Clinical Cancer Research.

[52]  Shingo Matsumoto,et al.  Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302 , 2015, Cancer & metabolism.

[53]  O. Paulson,et al.  Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV‐PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1‐13C]pyruvate , 2015, Magnetic resonance in medicine.

[54]  K. Tsai,et al.  IAPP driven metabolic reprogramming induces regression of p53 - deficient tumours in vivo , 2014, Nature.

[55]  J. Ardenkjaer-Larsen,et al.  Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner. , 2015, American journal of nuclear medicine and molecular imaging.

[56]  T. Akhurst,et al.  Lung cancer. , 2015, PET clinics.

[57]  J. Kurhanewicz,et al.  Simultaneous multiagent hyperpolarized 13C perfusion imaging , 2014, Magnetic resonance in medicine.

[58]  S. Nelson,et al.  Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells. , 2014, Cancer research.

[59]  R. Deberardinis,et al.  Real-time Detection of Hepatic Gluconeogenic and Glycogenolytic States Using Hyperpolarized [2-13C]Dihydroxyacetone* , 2014, The Journal of Biological Chemistry.

[60]  P. Larson,et al.  Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. , 2014, Cancer research.

[61]  Kevin M Johnson,et al.  Joint spatial‐spectral reconstruction and k‐t spirals for accelerated 2D spatial/1D spectral imaging of 13C dynamics , 2014, Magnetic resonance in medicine.

[62]  D. Mankoff,et al.  Molecular Imaging Biomarkers for Oncology Clinical Trials , 2014, The Journal of Nuclear Medicine.

[63]  David M. Wilson,et al.  Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization. , 2014, Chemical Society reviews.

[64]  Huiming Zhang.  The potential of hyperpolarized (13)C MRI in assessing signaling pathways in cancer. , 2014, Academic radiology.

[65]  He N. Xu,et al.  Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate. , 2014, Academic radiology.

[66]  R. Gillies,et al.  Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI. , 2014, Cancer research.

[67]  L. Court,et al.  Evaluation of Hyperpolarized [1-13C]-Pyruvate by Magnetic Resonance to Detect Ionizing Radiation Effects in Real Time , 2014, PloS one.

[68]  Johann de Jong,et al.  Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model , 2013, Nature Genetics.

[69]  Kieran Clarke,et al.  Hyperpolarized Butyrate: A Metabolic Probe of Short Chain Fatty Acid Metabolism in the Heart , 2013, Magnetic resonance in medicine.

[70]  Mikko I. Kettunen,et al.  Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.

[71]  R. Deberardinis,et al.  Real-Time Estimates of Hepatic Gluconeogenesis 1 Real-Time Detection of Hepatic Gluconeogenic and Glycogenolytic States Using Hyperpolarized [ 2-13 C ] Dihydroxyacetone * , 2014 .

[72]  H. Degani,et al.  Hyperpolarized 13C NMR studies of glucose metabolism in living breast cancer cell cultures , 2013, NMR in biomedicine.

[73]  Daniel B Vigneron,et al.  Non-invasive in vivo assessment of IDH1 mutational status in glioma , 2013, Nature Communications.

[74]  John Kurhanewicz,et al.  Combined parallel and partial fourier MR reconstruction for accelerated 8‐channel hyperpolarized carbon‐13 in vivo magnetic resonance Spectroscopic imaging (MRSI) , 2013, Journal of magnetic resonance imaging : JMRI.

[75]  Dawid Schellingerhout,et al.  A Catalyzing Phantom for Reproducible Dynamic Conversion of Hyperpolarized [1-13C]-Pyruvate , 2013, PloS one.

[76]  P. Larson,et al.  Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate , 2013, Science Translational Medicine.

[77]  John Kurhanewicz,et al.  Metabolic Reprogramming and Validation of Hyperpolarized 13C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor , 2013, The Prostate.

[78]  R. Gruetter,et al.  In vivo enzymatic activity of acetylCoA synthetase in skeletal muscle revealed by (13)C turnover from hyperpolarized [1-(13)C]acetate to [1-(13)C]acetylcarnitine. , 2013, Biochimica et biophysica acta.

[79]  R. Gillies,et al.  Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors. , 2013, Cancer research.

[80]  T. Jang,et al.  Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. , 2013, Neuro-oncology.

[81]  S. Ronen,et al.  Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells , 2013, NMR in biomedicine.

[82]  Albert P. Chen,et al.  Probing Early Tumor Response to Radiation Therapy Using Hyperpolarized [1-13C]pyruvate in MDA-MB-231 Xenografts , 2013, PloS one.

[83]  J. Kurhanewicz,et al.  Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas. , 2013, Cancer research.

[84]  Lisa M McShane,et al.  Publication of tumor marker research results: the necessity for complete and transparent reporting. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  L. Shankar.  The clinical evaluation of novel imaging methods for cancer management , 2012, Nature Reviews Clinical Oncology.

[86]  Paul E Kinahan,et al.  Quantitative assessment of dynamic PET imaging data in cancer imaging. , 2012, Magnetic resonance imaging.

[87]  Ashish Jindal,et al.  Comparison of kinetic models for analysis of pyruvate‐to‐lactate exchange by hyperpolarized 13C NMR , 2012, NMR in biomedicine.

[88]  G. Bodenhausen,et al.  High field dynamic nuclear polarization at 6.7 T: Carbon-13 polarization above 70% within 20 min , 2012 .

[89]  R. Gruetter,et al.  Localized in vivo hyperpolarization transfer sequences , 2012, Magnetic resonance in medicine.

[90]  C. Thompson,et al.  Therapeutic targets in cancer cell metabolism and autophagy , 2012, Nature Biotechnology.

[91]  Y. Wang,et al.  Glycolytic Inhibition Alters Anaplastic Thyroid Carcinoma Tumor Metabolism and Improves Response to Conventional Chemotherapy and Radiation , 2012, Molecular Cancer Therapeutics.

[92]  N. Henry,et al.  Cancer biomarkers , 2012, Molecular oncology.

[93]  L. V. Søgaard,et al.  Imaging Cerebral 2-Ketoisocaproate Metabolism with Hyperpolarized 13C Magnetic Resonance Spectroscopic Imaging , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[94]  K. Brindle,et al.  Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization. , 2012, Cancer research.

[95]  Kristen Scott,et al.  Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma , 2012, NeuroImage.

[96]  Daniel B. Vigneron,et al.  Validation of Hyperpolarized 13 C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor , 2012 .

[97]  J. Kurhanewicz,et al.  Hyperpolarized 13 C-Pyruvate Magnetic Resonance Reveals Rapid Lactate Export in Metastatic Renal Cell Carcinomas , 2012 .

[98]  John Kurhanewicz,et al.  Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging , 2011, Proceedings of the National Academy of Sciences.

[99]  B. Ross,et al.  Parahydrogen‐induced polarization (PHIP) hyperpolarized MR receptor imaging in vivo: a pilot study of 13C imaging of atheroma in mice , 2011, NMR in biomedicine.

[100]  F. Gallagher,et al.  Imaging pH with hyperpolarized 13C , 2011, NMR in biomedicine.

[101]  Neil Clarke,et al.  Dynamic nuclear polarization polarizer for sterile use intent , 2011, NMR in biomedicine.

[102]  P. Larson,et al.  In vivo measurement of normal rat intracellular pyruvate and lactate levels after injection of hyperpolarized [1-(13)C]alanine. , 2011, Magnetic resonance imaging.

[103]  Peder E. Z. Larson,et al.  13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. , 2011, Cell metabolism.

[104]  F. Gallagher,et al.  Hyperpolarized [1-13C]-Ascorbic and Dehydroascorbic Acid: Vitamin C as a Probe for Imaging Redox Status in Vivo , 2011, Journal of the American Chemical Society.

[105]  M. Lustig,et al.  Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies , 2011, Magnetic resonance in medicine.

[106]  D. Mankoff,et al.  PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake , 2011, Clinical Cancer Research.

[107]  C. Dang,et al.  Therapeutic targeting of cancer cell metabolism , 2011, Journal of Molecular Medicine.

[108]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[109]  F. Gallagher,et al.  Detection of Tumor Response to a Vascular Disrupting Agent by Hyperpolarized 13C Magnetic Resonance Spectroscopy , 2010, Molecular Cancer Therapeutics.

[110]  G Wilson Miller,et al.  Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129 , 2010, Proceedings of the National Academy of Sciences.

[111]  S. Meier,et al.  Imaging of branched chain amino acid metabolism in tumors with hyperpolarized 13C ketoisocaproate , 2010, International journal of cancer.

[112]  Y. Yen,et al.  In vivo application of sub-second spiral chemical shift imaging (CSI) to hyperpolarized 13C metabolic imaging: comparison with phase-encoded CSI. , 2010, Journal of magnetic resonance.

[113]  Michael Lustig,et al.  3D compressed sensing for highly accelerated hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancer , 2010, Magnetic resonance in medicine.

[114]  G. Radda,et al.  Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study , 2009, Cardiovascular research.

[115]  Ilwoo Park,et al.  Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. , 2010, Journal of magnetic resonance.

[116]  Lucio Frydman,et al.  Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells , 2009, Proceedings of the National Academy of Sciences.

[117]  Jan Henrik Ardenkjaer-Larsen,et al.  Dynamic Nuclear Polarization of [1-13C]pyruvic acid at 4.6 tesla. , 2009, Journal of magnetic resonance.

[118]  A. D. Van den Abbeele,et al.  Considerations for the Use of Imaging Tools for Phase II Treatment Trials in Oncology , 2009, Clinical Cancer Research.

[119]  S. Edge,et al.  Indications for breast MRI in the patient with newly diagnosed breast cancer. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[120]  Albert P. Chen,et al.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.

[121]  Pernille R. Jensen,et al.  Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.

[122]  Martin O Leach,et al.  Therapeutic target metabolism observed using hyperpolarized 15N choline. , 2008, Journal of the American Chemical Society.

[123]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[124]  Finbarr O'Sullivan,et al.  Molecular Imaging Research in the Outcomes Era: Measuring Outcomes for Individualized Cancer Therapy 1 Most of Cancer Imaging Thus Far Has Been Directed To- Ward Cancer Detection and Staging. the Principle Guiding , 2022 .

[125]  M. Thaning,et al.  Real-time metabolic imaging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[126]  W. Weber.  Positron emission tomography as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[127]  Joel Karp,et al.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[128]  R. Coleman,et al.  Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[129]  Bruce D Cheson,et al.  Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.

[130]  James H Thrall,et al.  Using imaging biomarkers to accelerate drug development and clinical trials. , 2005, Drug discovery today.

[131]  Jan H. Ardenkjær-Larsen,et al.  Molecular imaging with endogenous substances , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[132]  James H Thrall,et al.  Biomarkers in imaging: realizing radiology's future. , 2003, Radiology.

[133]  Sung-Cheng Huang,et al.  Anatomy of SUV , 2000 .

[134]  E. Gehan,et al.  Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? , 2000, Journal of the National Cancer Institute.

[135]  T. Walker,et al.  Spin-exchange optical pumping of noble-gas nuclei , 1997 .

[136]  Daniel P. Weitekamp,et al.  Parahydrogen and synthesis allow dramatically enhanced nuclear alignment , 1987 .

[137]  P. Felig.  The glucose-alanine cycle. , 1973, Metabolism: clinical and experimental.